Results 1 to 10 of about 2,009,602 (310)
Type 2 Diabetes in Youth [PDF]
Global Pediatric Health, 2020 The incidence of type 2 diabetes in children and adolescents in the United States rose at an annual rate of 4.8% between 2002-2003 and 2014-2015. Type 2 diabetes progresses more aggressively to complications than type 1 diabetes.
Goutham Rao MD, Elizabeth T. Jensen PhD
doaj +4 more sources
Tirzepatide for type 2 diabetes
Drugs in Context, 2023 One in ten adults worldwide is living with diabetes, with 95% having type 2 diabetes (T2D). Sustained glycaemic control in people with T2D is difficult to achieve despite recent advances in T2D management with the advent of glucagon-like peptide 1 ...
Sarah L Anderson, Joel C Marrs
doaj +3 more sources
Saxagliptin for type 2 diabetes
Diabetes, Metabolic Syndrome and Obesity, 2010 Antonio R Chacra, MDDiabetes Center, Federal University of São Paulo, BrazilAbstract: Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving glycemic control in ...
Antonio R Chacra, MD
doaj +7 more sources
Psychometric validation of type 2 Diabetes Distress Assessment System in an Indian type 2 diabetes population [PDF]
Scientific ReportsDiabetes distress (DD) significantly burdens and negatively impacts self-management and health outcomes in patients with type 2 diabetes (T2D). Early detection and management of DD are crucial for effective T2D management.
Baby Sharma +6 more
doaj +2 more sources
Biomarkers for type 2 diabetes
Molecular Metabolism, 2019 Background: The prevalence and incidence of type 2 diabetes (T2D), representing >90% of all cases of diabetes, are increasing rapidly worldwide.
Markku Laakso
doaj +3 more sources
The Lancet, 2018 The prevalence of type 2 diabetes is increasing at alarming rates throughout the world. Excess caloric intake and a sedentary lifestyle contribute to excess body fat accumulation which leads to insulin resistance. Over time, the pancreatic beta cells are unable to compensate for increased insulin demands and hyperglycemia occurs.
Remy, Boussageon +4 more
+7 more sources
BMJ Open, 2021 Introduction Medical treatment options for type 2 diabetes (T2D) have increased over the last decade and enhance the possibility of individualised treatment strategies where insulin is still one of them. In spite of the advancements in treatment options,
Kirsten Nørgaard +3 more
doaj +1 more source
BMJ Open, 2023 Objectives Cardiovascular disease (CVD) is a precarious complication of type 1 diabetes (T1D). Alongside glycaemic control, lipid and blood pressure (BP) management are essential for the prevention of CVD.
Bruce H R Wolffenbuttel +4 more
doaj +1 more source
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
BMJ Open Diabetes Research & Care, 2021 Introduction This study aimed to assess the association between fasting serum C-peptide levels and the presence of impaired awareness of hypoglycemia (IAH) in people with type 1 diabetes.Research design and methods We performed a cross-sectional study ...
Giesje Nefs +9 more
doaj +1 more source